Pulmonary fungal infection

On 31 August 2006, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 391. The active ingredient is amphotericin B (for inhalation use) for prevention of pulmonary fungal infection in patients deemed at risk.